Showing results (1-10 of 62) with videos related to
Sort By:
Pageof 7
Pharmaceuticals (Basel, Switzerland)|June 1, 2023
Checkpoint Inhibitor-Associated Scleroderma and Scleroderma MimicsMichael Macklin, Sudeep Yadav, Reem Jan, et al.Primary Care|May 16, 2018
Approach to Patients with Suspected Rheumatic DiseaseIaszmin Ventura, Pankti Reid, Reem JanBest Practice & Research. Clinical Rheumatology|December 20, 2022
Treatment of rheumatic adverse events of cancer immunotherapyPankti Reid, Laura C CappelliJournal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|June 13, 2022
Immune Checkpoint Inhibitor-Associated Myositis: A Distinct Form of Inflammatory MyopathyDidem Saygin, Nilasha Ghosh, Pankti ReidRheumatology Advances in Practice|April 11, 2024
Current and future advances in practice: aromatase inhibitor-induced arthralgiaSara Kim, Nan Chen, Pankti ReidRheumatic Diseases Clinics of North America|April 26, 2024
Immunotherapy Toxicity Management in Clinical Practice: Building the Clinical Infrastructure for Immune-related Adverse Event Evaluation and CareYael Klionsky, Alexa Simon Meara, Pankti ReidClinical Rheumatology|December 14, 2019
Teacher training for rheumatology fellows: a national needs assessment of fellows and program directorsPankti Reid, Eli M Miloslavsky, Anisha DuaJournal of Cancer Education : the Official Journal of the American Association for Cancer Education|April 6, 2023
Role-Specific Curricular Needs for Identification and Management of Immune-Related Adverse EventsAustin Wesevich, Gong He, Greg Tomczyk, et al.Best Practice & Research. Clinical Rheumatology|May 5, 2026
The management of rheumatic immune related adverse eventsPankti Reid, Namrata Singh, Tawnie Braaten, et al.Pharmaceuticals (Basel, Switzerland)|February 24, 2024
Immune Checkpoint Inhibitors and Lupus ErythematosusHans Vitzthum von Eckstaedt, Arohi Singh, Pankti Reid, et al.Pageof 7